Best Buy is entering the retail medical device market.
In an Oct. 9 announcement, the electronics retailer said it is preparing to sell prescription continuous glucose monitoring systems (CGMs) that will be delivered to patients’ homes.
Best Buy is partnering with Wheel — described as “a leading virtual care platform focused on delivering consumer-centric care — and HealthDyne, described as a pharmacy technology provider.
The retail giant will start by selling the Dexcom G7 Continuous Monitoring System through its BestBuy.com Web site. Patients accessing that site for their CGM prescriptions will be taken to a new platform: Wellness.BestBuyHealth.com.
“Leveraging the Salesforce platform, Best Buy is selling glucose monitors via a site powered by Commerce Cloud,” the announcement said. “With more CGM system options aimed to come soon after launch, this is the first time we will offer prescription-based medical devices to our customers.”
Best Buy Describes Its Ordering Process
The new Wellness.BestBuyHealth.com site will determine a customer’s eligibility to purchase the Dexcom G7. “If approved, the prescription will then be processed by HealthDyne and the device will be sent to your home,” the announcement said. “Although not available at launch, our goal is to soon allow those with an existing CGM prescription from their own physician to be able to upload that prescription into their profile and have the device sent to them.”
BestBuy will not accept insurance payments at the program’s launch, though the announcement added, “Customers with HSA/FSA/HRA funds may be able to be reimbursed for their purchase.”